Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0596-2026

FlexLab (FLX); Version: FLX-217-40; Recall

FlexLab (FLX); Version: FLX-217-40;

FDA recall Class II

Ongoing

FDA lists this Class II recall for FlexLab (FLX); Version: FLX-217-40;. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0596-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Oct 30, 2025
FDA report date
Dec 3, 2025
Quantity in commerce
14 units (1 US, 13 OUS)
Distribution
See key details
FDA cause
Device Design

What is being recalled?

FlexLab (FLX); Version: FLX-217-40;

Affected model & UDI checker

Search the exact identifiers published for Z-0596-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedFlexLab (FLX); Version: FLX-217-40;Check source notice07640172344002
FDA code information

UDI-DI: 07640172344002; Serial number: FXX.0004, FXX.0006, FXX.0009, FXX.0022, FXX.0023, FXX.0024, FXX.0027, FXX.0028, FXX.0034, FXX.0036, FXX.0041, FXX.0042, FXX.0043, FXX.0046;

View the original FDA recall notice

Why was this product recalled?

The Aliquoter Module (mALX) may generate secondary sample tubes without labels or with mismatched labels which may result in delayed results or erroneous results, this error occurs if the operators open the printer head of mALX to perform error recoveries or maintenance procedures and do not empty the printer tubes buffer to remove all the secondary sample tubes

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Inpeco S.A. take?

On October 30, 2025, "Urgent: Medical Device Correction" letters were sent to customers. Action to be taken: To avoid the occurrence of the described issue Inpeco recommends removing all the secondary sample tubes in the printer tubes buffer (red arrow) each time the printer cover (blue arrow) is opened for error recoveries and for preventive maintenance procedures. Your service provider will contact you to schedule the service visit to implement the corrective actions which include the installation of a new sensor, the software and firmware upgrade, and the operations manual update. Transmission of this Customer Letter: Until the service visit, please maintain awareness on this notice and apply the action recommended above. Please transfer this notice to whom it might concern. Please complete and return the Customer Letter Receipt Confirmation and Implementation Check form attached to this letter within 30 days directly to the email address specified in the email communication. If you have any questions, contact the Regulatory Affairs Department via email: regulatory.affairs@inpeco.com.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA classification recorded

  3. FDA notice posted

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology